UT Health researchers developing new drug to fight therapy-resistant ER-positive breast cancer
August 9, 2017
SAN ANTONIO (Aug. 9, 2017) ― Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors. Ratna Vadlamudi, Ph.D., […]
